PE managers are beginning to redirect capital toward deals in pharma services as the healthcare services vertical succumbs to various market pressures. Pharma services are related to the development and commercialization of biopharmaceutical drugs, while healthcare services are those offered by medical providers in hospitals, clinics and other facilities. PitchBook’s Q1 2024 Launch Report: Pharma Services shows the sector had a slow Q1 start with approximately 50 deals announced or completed, down from 67 deals in the previous quarter, reflecting deal trends in the broader healthcare sector.
Read the full article: More Pharma Services Deals Expected to Emerge from Incubation //
Source: https://pitchbook.com/news/articles/more-pharma-services-deals-expected-to-emerge-from-incubation